U.S. Professional Services Stock News

Kulicke and Soffa Industries recently reported earnings per share that nearly tripled, supported by strong demand for its AI-focused wire bonding and advanced packaging equipment used in data center chip assembly. At the same time, Senior Vice President Nelson Wong sold 15,000 shares worth about US$1.71 million, contributing to a year of exclusively insider share sales that investors may view alongside the company’s AI-driven momentum. Now, we’ll examine how this AI-related demand surge...

Bristol Myers Squibb (NYSE:BMY) reported positive late-stage clinical trial results for two multiple myeloma candidates. The company announced successful Phase III data for mezigdomide in combination with Kyprolis and dexamethasone. Early data for its CAR T-cell therapy arlocabtagene autoleucel showed a strong response rate with a manageable safety profile. The results were presented at the European Hematology Association Congress 2026. Bristol Myers Squibb is a global biopharmaceutical...

Earlier this month, Dolby Laboratories and NBCUniversal announced that Peacock streamed Telemundo’s live Spanish-language coverage of all 104 FIFA World Cup 2026 matches in Dolby Vision and Dolby Atmos using Dolby AC-4, marking the first commercial use of this codec by a video streamer. Beyond enhancing picture and sound, this rollout positions Dolby’s AC-4 and immersive formats at the core of a high-profile global sports event, reinforcing its role as a go-to technology partner for...

Earlier this month, Ouster, Inc. announced it had expanded its long-term manufacturing partnership with Benchmark Electronics, Inc. to support high-volume, automated production of Ouster’s new Rev8 OS lidar sensor family across industrial, robotics, automotive, and smart infrastructure markets using Benchmark’s global network and integrated microelectronics and optical capabilities. This deeper role in building complex, ruggedized Rev8 sensors under a planned 10-year production program...

Amer Sports recently reported a strong first quarter of 2026, with revenue, adjusted margins, and earnings per share all exceeding expectations on the back of broad-based brand, channel, and regional strength. Growth was especially powered by Salomon’s apparel and Arc’teryx’s omnichannel performance, as both direct-to-consumer and wholesale channels delivered double-digit revenue gains across every major geography. We’ll now examine how Amer Sports’ broad-based outperformance, particularly...

How Ladder Capital Stock Has Been Performing Recently Ladder Capital (LADR) has drawn investor attention after a mixed run in its share price, with the stock down over the year to date but showing gains over the past 3 months and year. This performance sits against reported revenue of $216.26 million and net income of $55.012 million, figures that help frame how the market is currently pricing this US$1.31b real estate investment trust. See our latest analysis for Ladder Capital. The latest...

Coach, part of Tapestry (NYSE:TPR), has launched &Coach, a digital luxury content platform co-created with Gen Z. The platform focuses on social first storytelling and participatory campaigns, with younger creators embedded in the process. &Coach is intended to reshape how the Coach brand builds community and relevance with younger luxury consumers. Tapestry, trading at $145.87, sits behind Coach as its flagship brand and is leaning into a content driven approach to connect with younger...

Euronet Worldwide (EEFT) stock has been drawing attention after a period of mixed share performance, with the price closing at $67.03 and returns weaker over the past year and past 3 months. See our latest analysis for Euronet Worldwide. Recent trading suggests Euronet Worldwide’s short term share price momentum has been patchy, and the share price weakness lines up with a much steeper decline in total shareholder return over the past five years. If Euronet Worldwide’s recent swings have you...

Tariffs, shifting trade rules, and pressure on global supply chains are reshaping how investors think about US manufacturing stocks. Instead of relying on smooth cross-border trade, markets are reassessing companies that produce more at home and can better control their costs and inputs. This article looks at three US Domestic Manufacturing screener stocks that are directly exposed to these trade headlines and may react in different ways as policies evolve. Each stock is assessed on its...

With Kevin Warsh preparing for his first post-meeting press conference and the Federal Reserve keeping rates at 3.6% while inflation sits at 4.2%, many investors are rethinking how much risk they want to carry. Large-cap defensive stocks, often backed by steady dividends and stronger balance sheets, can look relatively appealing when rate cuts seem less likely and market swings pick up. This article highlights 3 stocks from our Large-Cap Defensive Stocks screener that appear positively...

With markets under pressure from a more hawkish Federal Reserve tone, rising 10-year Treasury yields, and broad weakness across sectors, it can feel harder than ever to decide which large-cap stocks deserve space in your portfolio. Quality, financial strength, and consistent execution take on extra importance when borrowing costs rise and megacap tech stocks such as Meta, Microsoft, and Amazon come under renewed scrutiny. This article highlights three large-cap stocks from a Quality Large-Cap...

With the Federal Reserve hinting at possible rate hikes in 2026 and inflation holding at 4.2%, value stocks are back in focus for investors who care about price tags as much as potential. Higher-for-longer rates can reward companies with resilient balance sheets and sensible valuations, while putting pressure on those priced for perfection. This article highlights three value stocks from our screener that are closely exposed to the latest Fed and inflation news. It explains why some investors...

AAON (AAON) raised its 2026 revenue growth outlook to 40% to 45%, citing record backlog, expanding capacity, and improving production execution, particularly at BASX, as key supports for the stock's recent move. See our latest analysis for AAON. The latest guidance upgrade lands on top of strong momentum in AAON stock, with a 90 day share price return of 66.6% and a 1 year total shareholder return of 86.58%. However, the 30 day share price move has been roughly flat, which may hint that...

In recent months, UroGen Pharma resolved a patent dispute with Teva Pharmaceuticals by granting a non-exclusive license for a generic version of Jelmyto starting 15 September 2030, while reporting modest Jelmyto growth and significantly stronger first-quarter sales for its newer therapy, Zusduri. This combination of a long-dated generic entry and early commercial momentum for Zusduri reshapes how investors weigh UroGen’s product concentration and revenue-risk profile. With the Teva...

Insider Selling and Valuation Concerns Put Impinj Stock in Focus Impinj (PI) shares fell 5.0% on June 16, 2026, after renewed attention on valuation, with the stock trading 5.5% above its estimated intrinsic value and recent insider selling totaling US$49.4 million. See our latest analysis for Impinj. The latest drop in Impinj's share price fits into a mixed picture, with a 23.29% 90 day share price return contrasting with a year to date share price decline of 31.35%. At the same time, the 5...

If you are wondering whether Corcept Therapeutics stock is still attractively priced after a strong run, the key question now is how its current share price compares with a reasonable view of fair value. The stock last closed at US$81.75, with returns of 4.6% over the past week, 48.3% over the past month, 114.0% year to date, 14.8% over the past year, 264.0% over three years, and 267.3% over five years. These figures naturally raise questions about how much of the story might already be...

The Fed’s hawkish turn, with rates held at 3.5 to 3.75% and the next move likely a hike, has quickly reshaped expectations for dividend stocks. Higher yields on cash and bonds can pressure income stocks, but solid dividend growth companies with healthy balance sheets can still play a role for investors looking for reliable cash flows and potential income growth. This article looks at three dividend growth stocks from our screener that appear well positioned against this new rate backdrop and...

Wondering if Willis Towers Watson stock is priced attractively today or if the risks outweigh the potential reward? This article breaks down what the current share price might be implying. Willis Towers Watson last closed at US$260.03. While the stock has risen 1.2% over the past month, it is still down 20.3% year to date and 11.6% over the past year, with a gain of 16.1% over three years and 20.4% over five years. These mixed returns sit against an ongoing flow of industry and macro news...

Wondering if Yum China Holdings stock still offers value at current levels, or if the recent moves have already priced in the story? This article walks through what the numbers are saying right now. The share price closed at US$43.28, with returns that declined 1.2% over the past week, 4.8% over the past month, and 10.2% year to date. Over longer periods, the share price has risen 3.5% over the past year and declined 20.9% over three years and 30.0% over five years. These shifts can change...

Global inflation questions, shifting central bank policies and energy price swings have put resilience and reliability at the top of many investors’ wish lists. Aerospace and defense companies sit at the crossroads of government spending, long-term contracts and critical infrastructure, which can offer a different risk and return profile compared with more cyclical areas of the market. This Aerospace And Defense screener filters for companies that manufacture or provide services to these...

Earlier in June 2026, Waste Connections announced an 11.1% increase in its dividend, highlighting management’s emphasis on returning more cash to shareholders while running a large North American waste management network. The dividend hike comes even as the company faces signs of slowing demand and pressure on profitability, underscoring a tension between income-focused capital returns and operational headwinds. We’ll now examine how this sizable dividend increase, set against concerns about...

Earlier in June 2026, GH Research PLC reported full Phase 2a results for its inhaled Mebufotenin (GH001) in postpartum depression, showing rapid remission in all 10 patients, improved maternal functioning, and a favorable safety profile, with findings published in The Journal of Clinical Psychiatry and highlighted at the upcoming CINP 2026 congress. An additional practical insight from the trial was that drug levels in breast milk supported only a brief interruption of breastfeeding around...

Pomerantz LLP is investigating Futu Holdings (NasdaqGM:FUTU) after a Reuters report that Chinese regulators may penalize the broker for soliciting clients without an onshore license, bringing regulatory risk into focus. See our latest analysis for Futu Holdings. The investigation comes after a difficult period for Futu Holdings, with the share price down 46.2% year to date and 33.6% over 90 days. However, the three year total shareholder return is 152.7%, suggesting long term holders have...

John Wiley & Sons (WLY) closed FY 2026 with fourth quarter revenue of US$447.9 million and basic EPS of US$2.65, supported by trailing twelve month EPS of US$4.22 on revenue of US$1.68 billion. Over recent periods, the company has seen quarterly revenue move from US$404.6 million in FY 2025 Q3 to US$442.6 million in FY 2025 Q4 and then to US$447.9 million in FY 2026 Q4. Basic EPS shifted from a loss of US$0.43 in FY 2025 Q3 to US$1.27 in FY 2025 Q4 and US$2.65 in FY 2026 Q4, alongside...